Treatment of Patients with Dedifferentiated Liposarcoma (DDLPS) with the MDM2–p53 Antagonist Brigimadlin and P53 Function: A Longitudinal Analysis of Circulating Micrornas (mirnas) in a First-in-human Phase Ia/Ib Study.

JOURNAL OF CLINICAL ONCOLOGY(2024)

引用 0|浏览1
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要